001     57375
005     20200402210142.0
024 7 _ |2 pmid
|a pmid:17132044
024 7 _ |2 DOI
|a 10.1562/2006-08-25-RA-1014
024 7 _ |2 WOS
|a WOS:000245658000025
037 _ _ |a PreJuSER-57375
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biochemistry & Molecular Biology
084 _ _ |2 WoS
|a Biophysics
100 1 _ |a Skegro, D.
|b 0
|0 P:(DE-HGF)0
245 _ _ |a N-terminal and C-terminal Domains of Arrestin Both Contribute in Binding to Rhodopsin (dagger)
260 _ _ |a Malden, Mass.
|b Wiley-Blackwell
|c 2007
300 _ _ |a 385 - 393
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Photochemistry and Photobiology
|x 0031-8655
|0 15281
|v 83
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a Visual arrestin terminates the signal amplification cascade in photoreceptor cells by blocking the interaction of light activated phosphorylated rhodopsin with the G-protein transducin. Although crystal structures of arrestin and rhodopsin are available, it is still unknown how the complex of the two proteins is formed. To investigate the interaction sites of arrestin with rhodopsin various surface regions of recombinant arrestin were sterically blocked by different numbers of fluorophores (Alexa 633). The binding was recorded by time-resolved light scattering. To accomplish site-specific shielding of protein regions, in a first step all three wild-type cysteines were replaced by alanines. Nevertheless, regarding the magnitude and specificity of rhodopsin binding, the protein is still fully active. In a second step, new cysteines were introduced at selected sites to allow covalent binding of fluorophores. Upon attachment of Alexa 633 to the recombinant cysteines we observed that these bulky labels residing in the concave area of either the N- or the C-terminal domain do not perturb the activity of arrestin. By simultaneously modifying both domains with one Alexa 633 the binding capacity was reduced. The presence of two Alexa 633 molecules in each domain prevented binding of rhodopsin to arrestin. This observation indicates that both concave sites participate in binding.
536 _ _ |a Funktion und Dysfunktion des Nervensystems
|c P33
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK409
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Animals
650 _ 2 |2 MeSH
|a Arrestin: chemistry
650 _ 2 |2 MeSH
|a Arrestin: genetics
650 _ 2 |2 MeSH
|a Arrestin: metabolism
650 _ 2 |2 MeSH
|a Base Sequence
650 _ 2 |2 MeSH
|a Binding Sites
650 _ 2 |2 MeSH
|a Cattle
650 _ 2 |2 MeSH
|a Cysteine: chemistry
650 _ 2 |2 MeSH
|a DNA Primers: genetics
650 _ 2 |2 MeSH
|a Fluorescent Dyes
650 _ 2 |2 MeSH
|a Models, Molecular
650 _ 2 |2 MeSH
|a Mutagenesis, Site-Directed
650 _ 2 |2 MeSH
|a Photochemistry
650 _ 2 |2 MeSH
|a Protein Binding
650 _ 2 |2 MeSH
|a Protein Structure, Tertiary
650 _ 2 |2 MeSH
|a Recombinant Proteins: chemistry
650 _ 2 |2 MeSH
|a Recombinant Proteins: genetics
650 _ 2 |2 MeSH
|a Recombinant Proteins: metabolism
650 _ 2 |2 MeSH
|a Rhodopsin: metabolism
650 _ 2 |2 MeSH
|a Signal Transduction
650 _ 7 |0 0
|2 NLM Chemicals
|a Arrestin
650 _ 7 |0 0
|2 NLM Chemicals
|a DNA Primers
650 _ 7 |0 0
|2 NLM Chemicals
|a Fluorescent Dyes
650 _ 7 |0 0
|2 NLM Chemicals
|a Recombinant Proteins
650 _ 7 |0 52-90-4
|2 NLM Chemicals
|a Cysteine
650 _ 7 |0 9009-81-8
|2 NLM Chemicals
|a Rhodopsin
650 _ 7 |a J
|2 WoSType
700 1 _ |a Pulvermuller, A.
|b 1
|0 P:(DE-HGF)0
700 1 _ |a Krafft, B.
|b 2
|0 P:(DE-HGF)0
700 1 _ |a Granzin, J.
|b 3
|u FZJ
|0 P:(DE-Juel1)131965
700 1 _ |a Hofmann, K. P.
|b 4
|0 P:(DE-HGF)0
700 1 _ |a Büldt, G.
|b 5
|u FZJ
|0 P:(DE-Juel1)131957
700 1 _ |a Schlesinger, R.
|b 6
|u FZJ
|0 P:(DE-Juel1)VDB1421
773 _ _ |a 10.1562/2006-08-25-RA-1014
|g Vol. 83, p. 385 - 393
|p 385 - 393
|q 83<385 - 393
|0 PERI:(DE-600)2048860-9
|t Photochemistry and photobiology
|v 83
|y 2007
|x 0031-8655
856 7 _ |u http://dx.doi.org/10.1562/2006-08-25-RA-1014
909 C O |o oai:juser.fz-juelich.de:57375
|p VDB
913 1 _ |k P33
|v Funktion und Dysfunktion des Nervensystems
|l Funktion und Dysfunktion des Nervensystems
|b Gesundheit
|0 G:(DE-Juel1)FUEK409
|x 0
914 1 _ |y 2007
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k INB-2
|l Molekulare Biophysik
|d 31.12.2008
|g INB
|0 I:(DE-Juel1)VDB805
|x 0
970 _ _ |a VDB:(DE-Juel1)90215
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ISB-2-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ISB-2-20090406
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21